Letter to the Editor From Andereggen and Christ: “Clinical Characteristics and Outcomes of Prolactinomas in Children and Adolescents: A Large Retrospective Cohort Study”
The Journal of Clinical Endocrinology & Metabolism · 2024
DOI: 10.1210/clinem/dgae383 ↗Kurz gefasst
Leserbrief in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2024. Verfasst von Lukas Andereggen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Kantonsspital Aarau, 5001 Aarau, Switzerland. Hauptthemen laut MEDLINE: Pituitary Neoplasms, Prolactinoma. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 8 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
To the Editor, We read with great interest the recent article by Yang et al (1), which delves into the complex landscape of adulthood-onset (AO) prolactinoma patients, elucidating variations in symptoms and treatment outcomes based on sex and developmental stage. The number of patients included in the study is impressive. Providing a median follow-up of 3.2 years, the study underscores the predominant role of dopamine agonists (DAs) in treatment, unveiling a 23% resistance rate. Additionally, it accentuates surgery as an alternative for noninvasive prolactinomas, accomplishing enduring remission in 33% of cases within the surgical cohort (1). The correlation between tumor characteristics and treatment results provides valuable insights for endocrinologists and neurological surgeons dealing with this particular cohort. Our findings in young patients with prolactinomas align with Yang's cohort, highlighting endocrinopathies as the primary presentation and fewer encounters with macroadenomas in female patients compared to male patients (2). In females aged 21 and younger, 85% experienced menstrual disruption, often diagnosed with microprolactinomas (3), while in males, nonspecific hypogonadism symptoms contribute to a higher prevalence of macroprolactinomas (3), with elevated baseline prolactin (PRL) levels in males probably indicating a more extended disease duration in oligosymptomatic men (2).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Neurosurgery, Kantonsspital Aarau, 5001 Aarau, Switzerland.
- Faculty of Medicine, University of Bern, 3008 Bern, Switzerland.
- Department of Endocrinology, Diabetology and Metabolism, University Hospital of Basel, 4031 Basel, Switzerland.
ORCID-Profile: Lukas Andereggen, Emanuel Christ
Zitieren
APA
Andereggen, L., & Christ, E. (2024). Letter to the Editor From Andereggen and Christ: “Clinical Characteristics and Outcomes of Prolactinomas in Children and Adolescents: A Large Retrospective Cohort Study”. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae383
Vancouver
Andereggen L, Christ E. Letter to the Editor From Andereggen and Christ: “Clinical Characteristics and Outcomes of Prolactinomas in Children and Adolescents: A Large Retrospective Cohort Study”. The Journal of Clinical Endocrinology & Metabolism. 2024. doi:10.1210/clinem/dgae383
BibTeX
@article{Andereggen2024,
author = {Andereggen, Lukas and Christ, Emanuel},
title = {Letter to the Editor From Andereggen and Christ: “Clinical Characteristics and Outcomes of Prolactinomas in Children and Adolescents: A Large Retrospective Cohort Study”},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2024},
doi = {10.1210/clinem/dgae383}
}
EUVIMED